cells that developed in the thymus expressed the transcription factor RORt and the IL-23 receptor. These cells also expressed  4  1 integrins and the chemokine receptor CCR6 and were recruited to the lung, gut and liver. In the liver, these cells secreted IL-22 in response to self antigen and mediated host protection during inflammation. Thus, T H -17 cells, like T reg cells, can be selected by self antigens in the thymus.
CD4 + helper T cells are important in orchestrating immune responses. For nearly 20 years, the helper T cell differentiation paradigm consisted of two mutually exclusive pathways, T helper type 1 (T H 1) and T H 2, defined by the expression of distinct transcription factors and cytokines 1 . T H 1 cells express the transcription factor T-bet and produce interferon-γ (IFN-γ), which directs cell-mediated immunity by promoting the clearance of intracellular pathogens 2 and is responsible for delayed-type hypersensitivity reactions. T H 2 cells express the transcription factor GATA-3 and produce interleukin 4 (IL-4), IL-5 and IL-13, which facilitate host protection against extracellular parasites and are major effectors in atopic disease 2 . More recently, an IL-17-producing subset (T H -17) has been recognized as a third CD4 + helper T cell effector lineage that is critical during the early innate phase of the immune response 3, 4 . T H -17 cells promote the clearance of extracellular pathogens by recruiting neutrophils and by inducing the production of antimicrobial proteins and inflammatory factors from resident cells.
T H -17 cells express the transcription factors RORγt 5 (A002302) and RORα 6 , produce IL-22 (ref. 7) and IL-17F 8 in addition to IL-17 (IL-17A), and express the IL-23 receptor (IL-23R) 9 . Early work established IL-23 as a survival factor for T H -17 cells 4 and has shown that in vitro differentiation of T H -17 cells unexpectedly proceeds by a developmental pathway partially shared with the anti-inflammatory Foxp3 + regulatory T cell (T reg cell) population. The activation of naive T cells in vitro in the presence of transforming growth factor-β (TGF-β; A002271) alone promotes the development of T reg cells, and the addition of IL-6 diverts differentiation to the T H -17 lineage 10-12 . In further support of a relationship between these subsets, IL-2, a cytokine necessary for T reg cell survival 13 , constrains T H -17 differentiation; even in the presence of TGF-β and IL-6, IL-2 suppresses T H -17 development and expands T reg cell populations 14 . Inflammatory conditions, mimicked by the addition of IL-1, 'rescues' the inhibitory effect of IL-2 and restores T H -17 differentiation 15 . In addition, T reg cells can convert directly into T H -17 cells in particular inflammatory conditions 16 , and retinoic acid produced by dendritic cells in the gut abrogates inflammation by suppressing T H -17 differentiation and enhancing T reg cell differentiation 17 . Subsequent work has provided definitive data defining a developmental pathway common to these two subsets in that TGF-β operates in a concentration-dependent way, which allows induction of both the transcription factor Foxp3 and RORγt; differentiation on the T H -17 pathway is determined by factors such as IL-23 and IL-21, which prevent the direct binding of Foxp3 to RORγt 18 . Foxp3 and RORγt can both bind to Runx1, and Runx1 promotes RORγt-mediated induction of T H -17 cells while facilitating Foxp3 suppression of RORγt 19 . Further support for the common development of these two lineages has come from the observation that thymocytes that would in wild-type mice become T reg cells instead express RORγt and produce IL-17 in mice unable to express Foxp3 because of insertion of a gene encoding green fluorescent protein (GFP) in the Foxp3 locus 20 . Thus, in the absence of Foxp3, natural mechanisms selecting the T reg lineage default to the T H -17 lineage.
The presentation of self antigen, which is important for central tolerance through the removal of immature T cells expressing potentially autoreactive T cell antigen receptors (TCRs), is also necessary for the selection of self-reactive subsets of T cells. These most notably include 1 1 2 6 VOLUME 10 NUMBER 10 OctOBER 2009 nature immunology A r t i c l e s natural T reg cells 21, 22 , CD1d-restricted natural killer T cells 23 , CD8αα intraepithelial lymphocytes 24 and γδ T cells 25 . Thus, in addition to producing naive T cells that migrate to secondary lymphoid organs, where they await activation and differentiation, the thymus produces distinct, often smaller, populations of T cells that leave the thymus as differentiated effector populations with the ability to 'fine tune' the immune response. Here we sought to identify other effector cell subsets that are selected on the basis of self-reactivity. We specifically focused on the T H -17 subset because of its developmental relationship with T reg cells. We demonstrate that the lineage relationship between T reg and T H -17 cells can be extended to include development in the thymus in response to self antigen.
RESULTS

Self-reactivity enriches for T H -17 cells
To explore the influence of self-reactivity on the differentiation of distinct T cell subsets, we used a model of natural T reg cell enrichment in which mice express a TCR transgene as well as a transgene encoding a high-affinity cognate antigen for this TCR 21, 26 . We bred B10.BR (H-2 k ) mice bearing the AND TCR transgene specific for a peptide of pigeon cytochrome c (PCC) with mice expressing PCC under control of a major histocompatibility complex class I promoter 27 . As expected, these AND × PCC double-transgenic (DTg) mice showed altered thymocyte development compared with that of control singletransgenic (STg) mice expressing either the AND transgene or the PCC transgene ( Supplementary Fig. 1a ). DTg mice had a smaller but not eliminated peripheral CD4 + T cell population ( Fig. 1a) . Most of the mature CD4 + T cells in DTg mice expressed CD44 ( Fig. 1b) , which indicated an activated or memory phenotype. Consistent with published reports 21, 26 , DTg mice also showed enrichment for T reg cells, as determined by Foxp3 expression ( Fig. 1c) . T reg cells made up only a fraction of the T cell population in DTg mice; we focused our studies on the remaining non-T reg CD4 + T cells.
To determine the functional state of the peripheral CD4 + T cells in the DTg mice, we assessed their proliferation and cytokine production after stimulation with antigen in vitro. In comparison with cells from AND-STg mice, those from DTg mice required at least a log more antigen for activation ( Fig. 1d) , consistent with an 'antigen-tuning' model 28 . However, having reached the threshold for stimulation, DTg T cells showed proliferation kinetics similar to those of cells from AND-STg mice, as indicated by an identical proliferation index at higher antigen concentrations ( Fig. 1d) . In response to antigen, AND-STg T cells secreted significantly more IL-2 than did DTg T cells ( Fig. 1e) . However, DTg T cells produced more IL-17 and IFN-γ than did AND-STg T cells ( Fig. 1e) . Intracellular cytokine staining and analysis of Foxp3 expression established the presence of three distinct and enriched T cell subsets in spleens of DTg mice: T reg , T H -17 and T H 1 (Fig. 1f-h) .
Thymic selection of self-reactive T H -17 cells
The development of the T H -17 subset in DTg mice could occur intrathymically and/or peripherally, given the widespread tissue expression of the neo-self antigen PCC. We used intracellular cytokine staining to show that the CD4 + single-positive thymocyte pool from DTg mice contained populations enriched for IL-17-producing as well as Foxp3 + and IFN-γ + cells ( Fig. 2a,b) ; absolute numbers of T H -17 cells were also substantially greater in the thymus and lymph nodes of DTg mice than in those of AND-STg mice ( Supplementary  Fig. 1b ). To confirm that these cells were of thymic origin and were not recirculating from peripheral tissues, we sorted HSA + CD4 + CD8 − single-positive thymocytes ( Supplementary Fig. 2a,b ) and cultured them with PCC. Like splenocytes, these thymocytes produced IL-17 intracellularly ( Fig. 2c,d) . As further confirmation of their immature status, DTg thymocytes producing IL-17 expressed a GFP cassette regulated by the recombination-activating gene 2 (Rag2) promoter (RAG2:GFP) 29 , like CD4 + CD8 + double-positive thymocytes from the same mice; in comparison, IFN-γ-producing cells in the thymus had lower expression of GFP ( Fig. 2e ). Next we labeled CD4 + T cells from the lymph node and spleens of DTg mice with the cytosolic dye CFSE and transferred the cells into PCC-STg recipients to determine if they migrated to the thymus. At 48 h after transfer, we found that DTg T cells survived, albeit without proliferation (presumably due to TCR 'tuning') 28 , and populated the lymph node, lungs and liver but showed minimal movement to the thymus ( Fig. 2f and Supplementary  Fig. 2c ). Finally, we analyzed AND × TA.TIM-transgenic mice, in which MCC expression is restricted to thymic epithelial cells 30 . We found enrichment of IL-17-producing cells in the thymus and lymph node, as indicated by the increase in their percentage and absolute number similar to that found in DTg mice ( Fig. 2g ). Together these results demonstrated that IL-17-producing AND TCR-transgenic T cells develop in the thymus. In addition, given that the thymus restricted expression of self antigen in TA.TIM mice, they indicate that after export from the thymus, these cells are found in secondary lymphoid organs even in the absence of self antigen. We next sought to determine if DTg mice developed an inflammatory or autoimmune phenotype, given their enrichment for T H -17 cells in the setting of global expression of self antigen. We therefore monitored DTg mice up to 1 year of age and found that their survival curves were identical to those of AND-STg and wild-type mice ( Supplementary Table 1 ). Moreover, concentrations of cytokines and chemokines (IL-1α, IL-6, IL-10, IL-17, IFN-γ, IL-12 (p40), tumor necrosis factor, CCL3 (MIP-1α) and CCL5 (RANTES)), as well as immunoglobulin M and autoantibodies (to DNA), were equivalent in serum from 12-week-old DTg and wild-type mice; notably, both groups had lower concentrations of cytokines and antibodies than did age-matched autoimmune-prone MRL/Fas lpr mice ( Supplementary  Fig. 3a,b) . Serum concentrations of IL-17 and IFN-γ were similar in DTg and wild-type mice, which suggested that the T H -17 effector populations in DTg mice are present but are appropriately suppressed. In addition, after transfer to DTg recipients, naive AND-STg T cells allotype-marked by CD90.1 failed to differentiate into IL-17-producing cells (Supplementary Fig. 3c ). Thus, spontaneous skewing to T H -17 did not occur in the peripheral environment of DTg mice, in further support of the idea that the thymus is involved in T H -17 cell differentiation.
To demonstrate that our observations were not limited to one DTg system or to the B10.BR mouse strain, we also bred mice bearing the OT-II TCR transgene specific for a peptide of ovalbumin (OVA) in the context of I-A b (C57BL/6) with those expressing OVA under control of the promoter of the gene encoding chicken β-actin (Act-mOVA). The thymi and lymph nodes of these OT-II × OVA-double-transgenic mice were enriched for percentages and absolute numbers of T H -17 cells to a degree similar to that in the AND × PCC DTg mice ( Supplementary Fig. 4a-d) . The finding of a similar absolute number of T H -17 cells in two different double-transgenic systems of different strains and presumed affinity for neo-self antigen indicates that other factors such as local or circulating cytokines may contribute to development of this subset, analogous to the T reg cell dependence on IL-2 (ref. 13). Self-reactivity is presumably only one step in the pathway of thymic T H -17 cell differentiation.
In confirmation of the self-antigen specificity of the enriched T H -17 cell populations in DTg mice, stimulation of CD4 + T cells from DTg mice with PCC peptide induced proliferation ( Fig. 1d and Supplementary  Fig. 5a ), and IL-17 production ( Figs. 1e and 2c) . These experiments indicate that T H -17 thymocytes and splenocytes from DTg mice are specific for neo-self antigen, even in the setting of possible expression of endogenous TCR rearrangements in the transgenic T cells. Nonetheless, we went on to demonstrate that T H -17 enrichment also occurred in the thymi and spleens of Rag1 −/− OT-II × OVA double-transgenic mice (Supplementary Fig. 5b ). These data, in aggregate, indicate that in DTg mice, T H -17 cells may develop in the thymus after selection by neoself antigen, analogous to the development of natural T reg cells 21, 22 .
IL-6 and TGF- promote thymic T H -17 differentiation
IL-6 and TGF-β are critical for T H -17 differentiation in vitro [10] [11] [12] and in vivo 31, 32 . Thus, we sought to determine if the same cytokines were necessary for the development of thymus-derived T H -17 cells in the absence of overt inflammation. We used DTg mice bred to mice either lacking IL-6 or expressing a dominant negative form of the TGF-β receptor under control of the Cd4 promoter 33 . In both cases, the T H -17 population was significantly smaller in the thymus and in peripheral lymphoid organs, whereas the T reg and T H 1 populations were either unaffected or slightly larger 34 (Fig. 3a,b) . (Fig. 3c) . In contrast, lymph node CD4 + T cells from Ifng −/− DTg mice produced significantly more IL-17 after culture with PCC than did Ifng +/+ DTg lymph node CD4 + T cells (Fig. 3d) . The addition of IFN-γ to such cultures resulted in a dose-dependent decrease in IL-17 secretion (Fig. 3e) . Thus, whereas IL-6 and TGF-β influence T H -17 differentiation in the thymus, IFN-γ seems to regulate these cells once they are differentiated and has the potential to down-modulate IL-17 production during the course of an inflammatory response.
DTg T H -17 cells express CD28-CTLA-4 family members
In contrast to CD4 + T cells from AND-STg or wild-type mice, most CD4 + T cells in DTg mice, including both the T H -17 and T H 1 populations, expressed CD44, a marker of activated or memory T cells ( Figs. 1b and 4a) . However, T H -17 cells from DTg mice had higher expression of inducible costimulator (ICOS), a member of the CD28 superfamily and an important indicator of T cell activation 36 , than did the T H 1 subset. This observation suggested a difference in the basal activation status of the T H 1 and T H -17 subsets in DTg mice (Fig. 4b) . In contrast, there was lower expression of PD-1, an established negative regulator of T cells 37 , on T H -17 than on T H 1 cells (Fig. 4c) . This protein functionally distinguishes these two populations, as antibody-mediated blockade of PD-1 ligand in vitro enhanced the PCC-induced production of IFN-γ but had little effect on IL-17 production ( Fig. 4d) .
Migration of DTg T H -17 cells
In DTg mice, the liver, lungs, Peyer's patches and lamina propria showed greater enrichment for T H -17 cells than did the spleen (Fig. 5a) . In contrast, IFN-γ-producing cells 'preferentially' populated the spleen and liver (Fig. 5a) . To confirm that T H -17 cells had specific migration patterns distinct from those of populations that did not secrete IL-17, we purified total CD4 + T cells from the spleens and lymph nodes of DTg mice, labeled them with CFSE and transferred them into wild-type recipients. At 2 d after transfer, we found that in contrast to CD4 + T cells that lacked the ability to produce IL-17, those that made this cytokine had the greatest relative recruitment to the lamina propria, followed by the lungs, liver, lymph node and spleen (Fig. 5b) . We noted a different migration pattern for IFN-γ-producing cells (Supplementary Fig. 6a ). Of note, the transferred cells did not proliferate at these sites ( Supplementary Fig. 6b ), which indicated that their accumulation was due to migration and not local population expansion. Given the pattern of migration described above, we sought to determine if T H -17 cells isolated from spleens of DTg mice displayed unique markers that allowed selective peripheral homing 38 . Most DTg T H -17 cells expressed α 4 β 1 integrins, with heterogeneous expression of β 7 and α IEL but minimal expression of α 1 (Fig. 5c ). In addition, chemokine receptor analysis showed that the T cell compartment of DTg mice contained CD4 + T cells that expressed CCR3, CCR5, CCR6 (A000629), CCR9, CCR10 and CXCR3. Further inspection indicated that DTg T H -17 cells uniquely expressed CCR6, an established T H -17 cell-associated chemokine receptor 39 , but did not express any other inflammatory chemokine receptor tested (Fig. 5d) . These findings are consistent with the homing of DTg T H -17 cells to the liver and lungs, as these are sites of basal expression of CCL20, the ligand for CCR6 (ref. 40 ).
DTg T H -17 cells express RORt, IL-23R and IL-22
We next sought to determine if self-reactive T H -17 cells that develop intrathymically in the absence of inflammation share features with the previously described T H -17 cells 5, 9, 41, 42 . We sorted CD4 + T cells from lymph node and spleens of DTg mice into T reg , T H 1 and T H -17 populations on the basis of expression of CD44, CD25, ICOS and CCR6; we also sorted naive CD25 lo CD44 lo cells. Intracellular cytokine staining and RT-PCR analysis of IL-17 and IFN-γ confirmed the validity of this sorting strategy (Supplementary Fig. 7) . The T H -17 population uniquely expressed transcripts encoding RORγt, IL-23R and IL-22; in contrast, Il10 transcripts were expressed only in the T reg subset (Fig. 6a) . Using the same sorting strategy for thymocytes from DTg mice ( Supplementary  Fig. 8a) , we found that RORγt, IL-23R and IL-22 were also unique to the thymic T H -17 subset (Supplementary Fig. 8b ). This subset also had high expression of Rag1 mRNA, similar to CD4 + single-positive thymocytes that lacked CD44 expression and roughly 50-fold higher than that of lymph node cells ( Supplementary Fig. 8c ). Culture of splenocytes confirmed that DTg T cells produced IL-22 in an antigen-dependent manner (Fig. 6b) and that cells producing this cytokine were also present in the thymi of DTg mice (Fig. 6c) . Thus, thymic T H -17 cells obtained from DTg mice express lineage features of T H -17 cells that have been found before after in vitro skewing and in inflammatory models.
DTg T H -17 cells suppress hepatic inflammation via IL-22
To determine if AND TCR-transgenic T cells that produced IL-17 and IL-22 in response to self antigen were functional, we assessed their effect in a model of toxin-induced hepatitis 43 . We purified CD4 + T cells from DTg mice, depleted the populations of T reg cells and transferred them into PCC-expressing or wild-type recipients. Then, 48 h later, we exposed recipient mice to the hepatic toxin D-(+)galactosamine in the presence of lipopolysaccharide. Transfer of DTg T cells protected mice from the toxic effects of D-(+)-galactosamine and lipopolysaccharide, as shown by lower hepatic enzyme concentrations; the beneficial effect of DTg cells was enhanced by expression of PCC in the recipient mice (Fig. 6d) . An IL-22-blocking antibody abrogated the protective effect of DTg cells during hepatitis induction, whereas IL-22 blockade in the absence of DTg cells had no effect 1 1 3 0 VOLUME 10 NUMBER 10 OctOBER 2009 nature immunology A r t i c l e s ( Fig. 6e and Supplementary Fig. 9 ). Thus, IL-22 produced by selfreactive DTg cells can suppress inflammation-induced liver toxicity.
Thymic T H -17 cells in wild-type mice
Finally, to demonstrate that our findings were not merely an artifact of double-transgenic models, we sought to identify IL-17-producing cells in peripheral lymphoid organs and thymi of wild-type mice. In the lymph node, the overall T H -17 population was small but made up over 3% of the CD4 + CD44 + T cells (Fig. 7a) . These cells were unique in their expression of CCR6 and ICOS (Fig. 7b) , analogous to the T H -17 population identified in DTg mice. We also identified IL-17-producing CD4 + single-positive thymocytes in wild-type mice (Fig. 7c) ; these were characterized by lower TCRβ expression ( Fig. 7d) , consistent with self-reactivity. Thymic T H -17 cells also expressed GFP regulated by the Rag2 promoter 29 (Fig. 7e) , consistent with a thymic origin. IL-17 + thymocytes in wild-type mice, like those in DTg mice, expressed ICOS and CCR6 ( Fig. 7f and Supplementary   Fig. 8a ). With these last two markers, we were able to use the same sorting strategy as for DTg thymocytes (Supplementary Fig. 8a) to isolate IL-17-producing thymocytes from wild-type mice and confirm that they selectively expressed Rorc (RORγt), Il23r and Il22 mRNA (Fig. 7g) . We also found this population in CD1d-deficient mice (Supplementary Fig. 10a-d) , which demonstrated that they were not invariant natural killer T cells 44 . Thus, IL-17 + thymocytes and CD4 + T cells exist in wild-type mice even in the absence of inflammation.
DISCUSSION
Our work suggests that the present understanding of T H -17 cell differentiation needs to be expanded to include development in the thymus. We found IL-17 + thymocytes in two double-transgenic models, in much ('log fold') higher percentages and numbers than in AND-STg control mice. We also detected small populations of IL-17 + thymocytes in wild-type mice. Several experiments excluded the possibility that IL-17 + thymocytes originated in and recirculated from the periphery. In addition, DTg mice did not have an intrinsically heightened inflammatory environment that might spontaneously promote T H -17 differentiation in the periphery. Thymic T H -17 cells were selected on the basis of greater reactivity to self antigens in DTg mice, and they produced IL-17 and IL-22 after stimulation with neo-self antigen. Although we are uncertain if endogenous TCR rearrangement is involved in the development of these cells, the presence of IL-17 + splenocytes and thymocytes in Rag1 −/− DTg mice indicates that they can arise in the absence of such rearrangements. Thymic IL-17-producing cells in wild-type mice had lower expression of surface TCRβ than did other thymic populations, also suggestive of a self-reactive phenotype.
These findings extend the function of self-antigen presentation during thymic development from one originally thought to be limited to positive selection of functional T cells followed by deletion of autoreactive cells, an idea that has been expanded to include the selection of T reg cells 21, 22 , natural killer T cells 23 , CD8αα + cells 24 and γδ T cells 25 . These observations also strengthen the existing link between the development of T H -17 cells and that of natural T reg cells, although it is important to emphasize that the thymic T H -17 cells we describe showed effector 'programming' similar to that of nonclassical effector T cell populations, including γδ and natural killer T cells. Those two lineages offer a paradigm of how inherently selfreactive cells with rearranged TCRs can assist the innate immune system in host responses through recognition of self ligands and serve a nonredundant function in clearance of pathogens 45, 46 and/or down-modulation of inflammatory injury 47, 48 . Indeed, the thymic T H -17 cells we have described closely resemble γδ T cells in terms of effector function, in that they share IL-17 as a proinflammatory mediator 49 and have the potential to modulate peripheral inflammatory responses despite numerical inferiority relative to conventional effector T cells. The γδ T cells can be activated after recognition of self ligands that are upregulated in the periphery during inflammation (for example, the nonclassical major histocompatibility complex class I molecules T10 and T22; ref. 50). Thymic T H -17 cells suppressed hepatic inflammation through IL-22 secretion promoted by neo-self antigen recognition. Thus, effector ability after recognition of self antigen in peripheral inflammatory responses reflects an already established paradigm.
Thymus-derived T H -17 cells seeded peripheral organs, with enrichment in the lamina propria, liver, lung and Peyer's patches in DTg mice. Although it is formally possible that such cells arose as a consequence of differentiation in secondary lymphoid organs, as noted above, several lines of evidence suggest that this is not the case. In addition, the phenotype of the thymic T H -17 cells (expression of α 4 β 1 integrins and CCR6) favors their migration to such sites as the lung and liver 40 . Our observations follow the identification in human thymi and umbilical cord blood of CD3 + CD4 + CD161 + cells that express RORt, IL-23R and CCR6 and produce IL-17 after activation and stimulation with IL-1 and IL-23 (ref. 54 ). This work suggested that thymus-derived cells could be precursors of peripheral T H -17 cells in humans, an idea supported by the finding that CD161 + IL-17 + cells can be isolated from the intestinal tissue of patients with Crohn's disease 55 Additional work is needed to determine if thymic T H -17 cells, like previously described T H -17 cells, make IL-17F; this cytokine may exert immunoregulatory functions in allergic responses 51 . Thus, the thymic T H -17 population that migrates to the lung may protect the host against allergic lung injury through IL-17F secretion. The balance between the secretion of cytokines with pro-and anti-inflammatory potential, in concert with the tissue-specific expression of their receptors, presumably would resolve the paradox of a self-reactive population that can secrete cytokines with either property. In agreement with that, it is likely that IL-17 production is carefully regulated so that its production is restricted to situations that demand inflammation. Simultaneous production of a potentially protective cytokine such as IL-22 may promote the survival of cells expressing IL-22R during the highly toxic inflammation that thymic T H -17 cells help to create 52 . At the same time, secretion of IL-22 would not necessarily subjugate the proinflammatory function of IL-17, given the lack of IL-22R expression on cells of the immune response.
Unexpectedly, basal IL-6 concentrations, in the absence of obvious inflammation in DTg mice, determined the size of the thymic T H -17 population. Although the source of the cytokines required for thymic T H -17 cell development is not yet clear, we postulate that during inflammation, IL-6 produced after innate cell activation in the periphery operates in a feedback loop on the thymus to enhance the production of T H -17 cells at the expense of natural T reg cells. In an analogous regulatory loop, natural T reg cells in the thymus 53 might regulate thymic T H -17 development. Thymic T H -17 cells depend on TGF-β for optimal development; a possible source of this cytokine is natural T reg cells. We propose that during early T cell development, thymic IL-2 concentrations continue to increase with the expanding mature T cell compartment, reaching a critical abundance around day 3, which allows skewing of T reg cells from the self-reactive compartment 13 . As the T reg population expands, it serves as an IL-2 'sink' to lift the restriction of T H -17 lineage commitment by this cytokine 14 and produces TGF-β to promote T H -17 differentiation. Thus, the environment may directly regulate the balance between the development of T reg and T H -17 subsets from a common precursor. Thus, T reg enrichment of the type we observed in DTg mice may be a necessary component of natural T H -17 development.
Rapid effector ability and self-reactivity may explain why the thymic T H -17 population has been preserved in an immune system that also has induced IL-17-producing cells that recognize foreign antigens. Thymic T H -17 cells in DTg mice had a TCR signaling threshold set at least a 'log fold' above TCR-STg cells, which suggests that activation of the former is limited to conditions with greater presentation of self antigen, such as during pathogen challenge with associated tissue injury. If present in wild-type mice, such a phenotype presumably would enable the thymic subset to evaluate the severity of infection by the amount of tissue destruction, and after presentation of self peptides, resident self-reactive T H -17 cells could promote a robust response, including rapid neutrophil recruitment. Thus, the T H -17 subset would be able to direct the immune response according to the severity of infection, with host protection mediated by IL-22, whose effects are restricted to cells not of the immune system 52 . Although the evolutionary retention of the thymic IL-17-producing subset indicates an overall host benefit, its careful regulation can presumably be delinquent, given the appropriate environmental trigger in a genetically susceptible individual.
